A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.
Half of all human cancers lose p53 function by missense mutations, with an unknown fraction of these containing p53 in a self aggregated amyloid like state. Here we show that a cell penetrating peptide, ReACp53, designed to inhibit p53 amyloid formation, rescues p53 function in cancer cell lines and in organoids derived from high grade serous ovarian carcinomas (HGSOC) an aggressive cancer characterized by ubiquitous p53 mutations. Rescued p53 behaves similarly to its wild type counterpart in regulating target genes, reducing cell proliferation and increasing cell death. Intraperitoneal administration decreases tumor proliferation and shrinks xenografts in vivo. Our data show the effectiveness of targeting a specific aggregation defect of p53 and its potential applicability to HGSOCs.
Cancer cell